UBS/CALL/GALENICA/70.002/0.05/20.09.24 | Market Closed - Swiss Exchange 11:20:00 2024-06-13 EDT | ||
| 0.25 CHF | -7.41% |
|
| Current month | -16.67% | ||
| 1 month | +31.58% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
GALENICA AG
Latest news about GALENICA AG
| Date | Price | Change |
|---|---|---|
| 24-06-13 | 0.25 | -7.41% |
| 24-06-12 | 0.27 | -3.57% |
| 24-06-10 | 0.28 | -6.67% |
Delayed Quote Swiss Exchange
Last update June 13, 2024 at 11:20 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | GALENICA AG |
| Issuer | UBS |
| EGAL1U | |
| ISIN | CH1246593003 |
| Date issued | 2023-03-20 |
| Strike | 70 CHF |
| Maturity | 2024-09-20 (96 Days) |
| Parity | 20 : 1 |
| Emission price | 0.4 CHF |
| Emission volume | N/A |
| Settlement | physical |
| Currency | CHF |
Technical Indicators
| Highest since issue | 0.72 CHF |
|---|---|
| Lowest since issue | 0.15 CHF |
| Spread | 0.05 CHF |
| Spread % | 17.86% |
Company Profile
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Sector
-
Consensus: Galenica AG
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
73.65
CHF
Average target price
77
CHF
Spread / Average Target
+4.55%
- Stock Market
- Warrants
- EGAL1U Warrant
